Discover
Share the concern, treatment area and change you would like to explore
Loading
Please wait while the page content is assembled.


Wharton’s Jelly is the connective tissue surrounding the blood vessels inside the umbilical cord. It can be used as a source of mesenchymal stromal cells after suitable donation, screening, processing, and strict regulatory oversight.
Wharton’s Jelly is the connective tissue surrounding the blood vessels inside the umbilical cord. It can be used as a source of mesenchymal stromal cells after suitable donation, screening, processing, and strict regulatory oversight.
01 / How it works
Wharton’s Jelly mesenchymal stem cell therapy (WJ-MSC) in JB is planned around the treatment area, the technology or product involved and the result you hope to achieve. Your clinician will explain how the approach works and personalise the treatment details for you.
Wharton’s Jelly is the connective tissue surrounding the blood vessels inside the umbilical cord. It can be used as a source of mesenchymal stromal cells after suitable donation, screening, processing, and strict regulatory oversight.
Share the concern, treatment area and change you would like to explore
Shape the approach around your features, preferences and schedule
Experience a carefully planned session with clear guidance throughout
Follow simple aftercare and review how the treatment is progressing

02 / Visual guide
Wharton’s Jelly is the connective tissue surrounding the blood vessels inside the umbilical cord. It can be used as a source of mesenchymal stromal cells after suitable donation, screening, processing, and strict regulatory oversight.
Interactive treatment map
Tap a numbered point to move from your concern to the treatment approach, how it works and a personalised plan.

Start with the change you have noticed and the result you would like to explore.
Concerns & areas
Explore common areas and goals, then discuss which are most relevant to you.
Learn how this area can be approached within a personalised treatment plan.
Learn how this area can be approached within a personalised treatment plan.
Learn how this area can be approached within a personalised treatment plan.
Learn how this area can be approached within a personalised treatment plan.
Who may benefit
Joint pain should never be automatically assumed to require cellular treatment. An ethical WJ-MSC consultation in Johor Bahru starts with proper medical assessment.
Established Alternatives: We ensure you understand standard treatments first, including physiotherapy, oral medicines, hyaluronic acid injections, or whether an orthopaedic surgical referral is more appropriate.
What to discuss first
03 / Your treatment journey
A calm, well-explained experience at every stage.
Talk through the concern, your previous experiences and the result you would like to explore.
Review the treatment area, suitable options, expected experience and practical timing.
Arrive prepared and receive clear guidance throughout the treatment visit.
Leave with simple aftercare, helpful contact details and a plan for review.
If an authorised clinical pathway is deemed medically appropriate, the focus remains on safety, product traceability, and strict cold-chain management.
Follow-up & Rehabilitation: Any potential symptom changes from cellular treatments develop gradually. We schedule maintenance reviews to safely monitor your joint function and provide proper aftercare instructions, ensuring you understand when to rest and when to resume approved mobility exercises.
The primary goal discussed in research settings is often the potential for reducing pain and supporting the local joint environment. Results vary significantly based on disease severity, joint alignment, and individual response. Our patients from Tebrau, Permas Jaya, and Singapore appreciate that we do not rush the process or invent success percentages. We focus on safe, steady management rather than risking your health with unverified products.
04 / Practical expectations
Your experience will reflect the selected treatment, treatment area and individual response. These are the useful details to explore during your visit.
05 / Compare your options
Compare the treatment approach, the area it is designed for, the experience and the way results may develop—not only the name or price.
A useful starting point when you already know the treatment and want to understand it more clearly.
Opens a wider conversation about suitable approaches, timing, recovery and natural-looking results.
Treatment gallery
Explore the consultation, treatment setting and preparation through a carefully selected visual story.
Related concerns
Begin with the concern you notice, then discover treatment approaches and questions worth bringing to your consultation.
Patient knowledge guide
Four short questions explain the treatment, suitability and why assessment matters. This quiz educates—it does not diagnose or confirm treatment eligibility.
06 / Before you decide
At Medi Clinic, we do not use “stem cells” as a generic marketing term to bypass safety. If a clinical pathway is considered, we insist on exact product verification. We review the manufacturer’s Certificate of Analysis to check cell identity, viability, passage number, sterility, endotoxin levels, and mycoplasma testing. Living donor-derived cells carry potential risks, including infection, inflammatory reactions, and uncertain long-term effects. We educate patients thoroughly so they can provide truly informed consent.
Read about informed consent07 / Recovery
You will receive treatment-specific guidance on what to expect, how to care for the area and when to contact the clinic with a question.
Contact the clinic08 / FAQ
Helpful answers for planning your consultation and understanding the treatment experience.
If an authorised clinical pathway is deemed medically appropriate, the focus remains on safety, product traceability, and strict cold-chain management.
Wharton’s Jelly is the connective tissue surrounding the blood vessels inside the umbilical cord. It can be used as a source of mesenchymal stromal cells after suitable donation, screening, processing, and strict regulatory oversight.
No. WJ-MSCs are isolated from postnatal umbilical-cord connective tissue collected after a healthy birth. They are not embryonic stem cells, nor are they the same as umbilical-cord blood cells.
Possible risks include procedural pain, swelling, bleeding, infection, septic arthritis, inflammatory or immune reactions, allergy, product contamination, lack of benefit, unwanted cell behaviour, and uncertain long-term effects.
Yes. Medi Clinic can assess Singapore visitors near the Causeway, Tuas Second Link, Taman Molek, and Iskandar Puteri. Product legality, treatment availability, follow-up, and emergency planning must always be confirmed beforehand.
Wharton’s Jelly mesenchymal stem cell therapy (WJ-MSC) in JB is discussed using a clinician-selected approach in relation to the concern and treatment area discussed during consultation. The exact indication, treatment area, suitability, alternatives and follow-up plan require an individual clinical assessment.
Plan your next step
Share your goals with the Eco Botanic team and begin with a personalised consultation.